PubMed for id: 388585

Year	Number of Results
2002	1
2004	2
2006	2
2007	5
2008	3
2009	4
2010	2
2011	2
2013	3
2014	1
2015	2
2016	1
2017	2
2020	1
2021	1
2023	1
2024	0

1

NOTCH target gene HES5 mediates oncogenic and tumor suppressive functions in hepatocarcinogenesis.

Luiken S, Fraas A, Bieg M, Sugiyanto R, Goeppert B, Singer S, Ploeger C, Warsow G, Marquardt JU, Sticht C, De La Torre C, Pusch S, Mehrabi A, Gretz N, Schlesner M, Eils R, Schirmacher P, Longerich T, Roessler S. Luiken S, et al. Oncogene. 2020 Apr;39(15):3128-3144. doi: 10.1038/s41388-020-1198-3. Epub 2020 Feb 13. Oncogene. 2020. PMID: 32055024 Free PMC article.

2

HES5 promotes cellular proliferation of non-small cell lung cancer through STAT3 signaling.

Gu S, Zhang R, Gu J, Li X, Lv L, Jiang J, Xu Z, Wang S, Shi C, Wang DP, Wu C. Gu S, et al. Oncol Rep. 2017 Jan;37(1):474-482. doi: 10.3892/or.2016.5268. Epub 2016 Nov 22. Oncol Rep. 2017. PMID: 27878283

3

HES5 silencing is an early and recurrent change in prostate tumourigenesis.

Massie CE, Spiteri I, Ross-Adams H, Luxton H, Kay J, Whitaker HC, Dunning MJ, Lamb AD, Ramos-Montoya A, Brewer DS, Cooper CS, Eeles R; UK Prostate ICGC Group; Warren AY, Tavaré S, Neal DE, Lynch AG. Massie CE, et al. Endocr Relat Cancer. 2015 Apr;22(2):131-44. doi: 10.1530/ERC-14-0454. Epub 2015 Jan 5. Endocr Relat Cancer. 2015. PMID: 25560400 Free PMC article.

4

Repression of FBXW7 by HES5 contributes to inactivation of the TGF-β signaling pathway and alleviation of endometriosis.

Chen LJ, Hu B, Han ZQ, Liu W, Zhu JH, Chen XX, Li ZP, Zhou H. Chen LJ, et al. FASEB J. 2021 Feb;35(2):e20938. doi: 10.1096/fj.202000438RRR. FASEB J. 2021. PMID: 33496006

5

HES5 promotes cell proliferation and invasion through activation of STAT3 and predicts poor survival in hepatocellular carcinoma.

Zhu G, Shi W, Fan H, Zhang X, Xu J, Chen Y, Xu Z, Tao T, Cheng C. Zhu G, et al. Exp Mol Pathol. 2015 Dec;99(3):474-84. doi: 10.1016/j.yexmp.2015.09.002. Epub 2015 Sep 3. Exp Mol Pathol. 2015. PMID: 26342546

6

HES5 is a key mediator of Wnt-3a-induced neuronal differentiation.

Mußmann C, Hübner R, Trilck M, Rolfs A, Frech MJ. Mußmann C, et al. Stem Cells Dev. 2014 Jun 15;23(12):1328-39. doi: 10.1089/scd.2013.0557. Epub 2014 Mar 25. Stem Cells Dev. 2014. PMID: 24548083

7

Epigenetic inactivation of Notch-Hes pathway in human B-cell acute lymphoblastic leukemia.

Kuang SQ, Fang Z, Zweidler-McKay PA, Yang H, Wei Y, Gonzalez-Cervantes EA, Boumber Y, Garcia-Manero G. Kuang SQ, et al. PLoS One. 2013 Apr 26;8(4):e61807. doi: 10.1371/journal.pone.0061807. Print 2013. PLoS One. 2013. PMID: 23637910 Free PMC article.

8

The expressions of bHLH gene HES1 and HES5 in advanced ovarian serous adenocarcinomas and their prognostic significance: a retrospective clinical study.

Wang X, Fu Y, Chen X, Ye J, Lü B, Ye F, Lü W, Xie X. Wang X, et al. J Cancer Res Clin Oncol. 2010 Jul;136(7):989-96. doi: 10.1007/s00432-009-0744-8. Epub 2009 Dec 20. J Cancer Res Clin Oncol. 2010. PMID: 20091184 Free PMC article.

9

[Transcription factor network that regulates brain development].

Kageyama R. Kageyama R. No To Hattatsu. 2008 May;40(3):204-7. No To Hattatsu. 2008. PMID: 18524252 Review. Japanese. No abstract available.

10

Expression of differentiation associated protein Hes1 and Hes5 in cervical squamous carcinoma and its precursors.

Liu J, Ye F, Chen H, Lü W, Zhou C, Xie X. Liu J, et al. Int J Gynecol Cancer. 2007 Nov-Dec;17(6):1293-9. doi: 10.1111/j.1525-1438.2007.00930.x. Epub 2007 Mar 28. Int J Gynecol Cancer. 2007. PMID: 17388915

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

29 results

Results by year